E8-13491. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Improving Postpartum Follow up in Women With a Gestational Diabetes-Affected Pregnancy, Potential Extramural Project (PEP) 2008-R-02

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

Time And Date: 1 p.m.-3 p.m., June 18, 2008 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. This notice was published in the Federal Register on April 16, 2008, Volume 73, Number 74, page 20677. Additional time is required to complete the review of all applications submitted for this PEP. Applications being reviewed at the June 18, 2008, meeting will be reviewed by the same members of the original panel.

Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of “Improving Postpartum Follow up in Women with a Gestational Diabetes-Affected Pregnancy, PEP 2008-R-02.”

The National Center for Health Marketing determines that agency business requires its consideration of this matter on less than 15 days’ notice to the public and that no earlier notice of this meeting was possible.

Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone [phone].

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: June 9, 2008.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.